Compare INFQ & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INFQ | ITGR |
|---|---|---|
| Founded | 2007 | 1970 |
| Country | United States | United States |
| Employees | 205 | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.1B |
| IPO Year | 2026 | 2000 |
| Metric | INFQ | ITGR |
|---|---|---|
| Price | $13.46 | $93.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $20.00 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 19.0M | 352.1K |
| Earning Date | N/A | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $25.46 | $1.69 |
| Revenue Next Year | $25.00 | $6.53 |
| P/E Ratio | ★ N/A | $194.00 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $8.52 | $62.00 |
| 52 Week High | $21.28 | $123.49 |
| Indicator | INFQ | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 59.19 |
| Support Level | $13.15 | $82.58 |
| Resistance Level | $21.02 | $94.76 |
| Average True Range (ATR) | 1.38 | 2.37 |
| MACD | -0.21 | 0.02 |
| Stochastic Oscillator | 16.93 | 80.25 |
Infleqtion Inc developing and commercializing quantum technology products as part of a full-stack platform, which currently includes offerings such as quantum sensing, quantum computing, and software. Its quantum-enabled solutions are focused on addressing the world's pressing challenges, with technologies actively deployed across some sectors today, including defense and security, artificial intelligence (AI), energy optimization, space and frontier, materials discovery, and cybersecurity.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.